1-6 of 6
Wyndham H. Wilson
Close
Sort by
Journal Articles

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Clinical Trials & Observations
Rahul Lakhotia, Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani, Andrea N. Lucas, Seth M. Steinberg, Jonathan W. Friedberg, Brad S. Kahl, Richard F. Little, Nancy L. Bartlett, Ariela Noy, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5320–5324.
https://doi.org/10.1182/bloodadvances.2023010223
Published: 2023
Journal Articles

Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial

Clinical Trials & Observations
Peter W. M. Johnson, Sriram Balasubramanian, Brendan Hodkinson, S. Martin Shreeve, Steven Sun, Srimathi Srinivasan, Andrew J. Steele, Jessica Vermeulen, Laurie H. Sehn, Wyndham H. Wilson
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2008–2017.
https://doi.org/10.1182/bloodadvances.2022009389
Published: 2023
Includes: Supplemental data
Journal Articles

Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment

Clinical Trials & Observations
Catherine Lai, Diane E. Cole, Seth M. Steinberg, Nicole Lucas, Eva Dombi, Christopher Melani, Mark Roschewski, Frank Balis, Brigitte C. Widemann, Wyndham H. Wilson
Journal: Blood Advances
Blood Adv (2023) 7 (4): 529–532.
https://doi.org/10.1182/bloodadvances.2022007431
Published: 2023
Includes: Supplemental data
Journal Articles

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Clinical Trials & Observations
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle Saba, Liza Lindenberg, Esther Mena, Ethan Bergvall, Andrea Nicole Lucas, Allison Jacob, Erik Yusko, Seth M. Steinberg, Elaine S. Jaffe, Adrian Wiestner, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2667–2680.
https://doi.org/10.1182/bloodadvances.2021006397
Published: 2022
Includes: Supplemental data
Journal Articles

Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL

Clinical Trials & Observations
Milos D. Miljkovic, Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Nicole Lucas, Allison Jacob, Erik Yusko, Elaine S. Jaffe, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4198–4210.
https://doi.org/10.1182/bloodadvances.2020003679
Published: 2021
Includes: Supplemental data
Journal Articles

Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma

Clinical Trials & Observations
Sham Mailankody, Dickran Kazandjian, Neha Korde, Mark Roschewski, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mary Kwok, Yong Zhang, Adriana Zingone, Laurence Lamy, Rene Costello, Candis Morrison, Malin Hultcrantz, Austin Christofferson, Megan Washington, Martin Boateng, Seth M. Steinberg, Maryalice Stetler-Stevenson, William D. Figg, Elli Papaemmanuil, Wyndham H. Wilson, Jonathan J. Keats, Ola Landgren
Journal: Blood Advances
Blood Adv (2017) 1 (22): 1911–1918.
https://doi.org/10.1182/bloodadvances.2017005934
Published: 2017